UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Upregulation of miR-24 promotes cell proliferation by targeting NAIF1 in non-small cell lung cancer

Tumor biology, 2015-05, Vol.36 (5), p.3693-3701

2015

Volltextzugriff (PDF)

FAK inhibitor PF-562271 inhibits the migration and proliferation of high-grade serous ovarian cancer cells through FAK and FAK mediated cell cycle arrest

Medical oncology (Northwood, London, England), 2023-06, Vol.40 (8), p.215-215, Article 215

2023

Volltextzugriff (PDF)

Downregulation of long noncoding RNA PVT1 attenuates paclitaxel resistance in glioma cells

Cancer biomarkers : section A of Disease markers, 2018-01, Vol.23 (3), p.447-453

2018

Volltextzugriff (PDF)

SOX7 is associated with the suppression of human glioma by HMG-box dependent regulation of Wnt/β-catenin signaling

Cancer letters, 2016-05, Vol.375 (1), p.100-107

2016

Volltextzugriff (PDF)

Effect of prone and supine treatment positions for postoperative treatment of rectal cancer on target dose coverage and small bowel sparing using intensity-modulated radiation therapy

Translational cancer research, 2020-02, Vol.9 (2), p.491-499

2020

Volltextzugriff (PDF)

Inhibition of SHP-2 promotes radiosensitivity in glioma

Molecular medicine reports, 2015-09, Vol.12 (3), p.3563-3568

2015

Volltextzugriff (PDF)

N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies

Virologica Sinica, 2015-12, Vol.30 (6), p.449-456

2015

Volltextzugriff (PDF)

Hsa_circRNA_102002 facilitates metastasis of papillary thyroid cancer through regulating miR-488-3p/HAS2 axis

Cancer gene therapy, 2021-04, Vol.28 (3-4), p.279-293

2021

Volltextzugriff (PDF)

Bazedoxifene exhibits growth suppressive activity by targeting interleukin‐6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma

Cancer science, 2019-03, Vol.110 (3), p.950-961

2019

Volltextzugriff (PDF)

C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis

PloS one, 2013-11, Vol.8 (11), p.e79137-e79137

2013

Volltextzugriff (PDF)

JNK-dependent phosphorylation and nuclear translocation of EGR-1 promotes cardiomyocyte apoptosis

Apoptosis (London), 2022-04, Vol.27 (3-4), p.246-260

2022

Volltextzugriff (PDF)

Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study

Journal for immunotherapy of cancer, 2020-06, Vol.8 (1), p.e000437

2020

Volltextzugriff (PDF)

Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

Liver cancer (Basel ), 2023-10, Vol.12 (5), p.405-444

2023

Volltextzugriff (PDF)

Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition)

Journal of hematology and oncology, 2019-02, Vol.12 (1), p.16-11, Article 16

2019

Volltextzugriff (PDF)

The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH -MYCN transgenic neuroblastoma mouse model

Cancer letters, 2017-08, Vol.400, p.61-68

2017

Volltextzugriff (PDF)

Addition of PI3K/AKT/mTOR inhibitors to fulvestrant for advanced HR+/HER2- breast cancer: a systematic review and meta-analysis

Future oncology (London, England), 2023-06, Vol.19 (20), p.1439-1450

2023

Volltextzugriff (PDF)

Clonal hematopoiesis in primary immune thrombocytopenia

Blood cancer journal (New York), 2022-03, Vol.12 (3), p.40-40, Article 40

2022

Volltextzugriff (PDF)

Cardiac magnetic resonance‐based layer‐specific strain in immune checkpoint inhibitor‐associated myocarditis

ESC Heart Failure, 2024-04, Vol.11 (2), p.1061-1075

2024

Volltextzugriff (PDF)

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

Liver cancer (Basel ), 2020-12, Vol.9 (6), p.682-720

2020

Volltextzugriff (PDF)

Nivolumab-associated DRESS in a genetic susceptible individual

Journal for immunotherapy of cancer, 2021-10, Vol.9 (10), p.e002879

2021

Volltextzugriff (PDF)

The efficacy of bevacizumab compared with other targeted drugs for patients with advanced NSCLC: a meta-analysis from 30 randomized controlled clinical trials

PloS one, 2013-04, Vol.8 (4), p.e62038-e62038

2013

Volltextzugriff (PDF)

Inhibition of Angiogenesis and Extracellular Matrix Remodeling: Synergistic Effect of Renin-Angiotensin System Inhibitors and Bevacizumab

Frontiers in oncology, 2022-07, Vol.12, p.829059-829059

2022

Volltextzugriff (PDF)

Fruquintinib plus paclitaxel versus paclitaxel as second-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma (FRUTIGA): A randomized, multicenter, double-blind, placebo-controlled, phase 3 study

Journal of clinical oncology, 2024-02, Vol.42 (36_suppl), p.438780-438780

2024

Volltextzugriff (PDF)

USP35 promotes cell proliferation and chemotherapeutic resistance through stabilizing FUCA1 in colorectal cancer

Oncogenesis (New York, NY), 2023-03, Vol.12 (1), p.12-12, Article 12

2023

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Aktive Filter

ThemaPhysical Sciences

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(58)

Sprache

Englisch
(58)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Upregulation of miR-24 promotes cell proliferation by targeting NAIF1 in non-small cell lung cancer

FAK inhibitor PF-562271 inhibits the migration and proliferation of high-grade serous ovarian cancer cells through FAK and FAK mediated cell cycle arrest

Downregulation of long noncoding RNA PVT1 attenuates paclitaxel resistance in glioma cells

SOX7 is associated with the suppression of human glioma by HMG-box dependent regulation of Wnt/β-catenin signaling

Effect of prone and supine treatment positions for postoperative treatment of rectal cancer on target dose coverage and small bowel sparing using intensity-modulated radiation therapy

Inhibition of SHP-2 promotes radiosensitivity in glioma

N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies

Hsa_circRNA_102002 facilitates metastasis of papillary thyroid cancer through regulating miR-488-3p/HAS2 axis

Bazedoxifene exhibits growth suppressive activity by targeting interleukin‐6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma

C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis

Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study

JNK-dependent phosphorylation and nuclear translocation of EGR-1 promotes cardiomyocyte apoptosis

Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study

Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition)

The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH -MYCN transgenic neuroblastoma mouse model

Addition of PI3K/AKT/mTOR inhibitors to fulvestrant for advanced HR+/HER2- breast cancer: a systematic review and meta-analysis

Clonal hematopoiesis in primary immune thrombocytopenia

Cardiac magnetic resonance‐based layer‐specific strain in immune checkpoint inhibitor‐associated myocarditis

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

Nivolumab-associated DRESS in a genetic susceptible individual

The efficacy of bevacizumab compared with other targeted drugs for patients with advanced NSCLC: a meta-analysis from 30 randomized controlled clinical trials

Inhibition of Angiogenesis and Extracellular Matrix Remodeling: Synergistic Effect of Renin-Angiotensin System Inhibitors and Bevacizumab

Fruquintinib plus paclitaxel versus paclitaxel as second-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma (FRUTIGA): A randomized, multicenter, double-blind, placebo-controlled, phase 3 study

USP35 promotes cell proliferation and chemotherapeutic resistance through stabilizing FUCA1 in colorectal cancer

Aktive Filter

Suchergebnisse filtern